cytosorbents.com (CTSO) Short-Term Debt to Capital

The Cytosorbents (CTSO) market price chart reflects the dynamics of a company whose revenue is based on the high margins of sorption cartridges and economies of scale as sales grow. The business develops automated blood filtration systems that minimize human error through digital control. These purification technologies are integrated into intensive care infrastructure, positioning the company as a critical link in the therapy of systemic inflammation. The indicator is 0.00.

This indicator determines the proportion of liabilities maturing within one year relative to equity, assessing the issuer's ability to service current loans without risking insolvency. By analyzing the short-term leverage ratio, an investor determines the financial cushion of Cytosorbents (CTSO) for scaling CytoSorb cartridge production and expanding into blood purification system markets for critical care therapy.